Internal Server Error

List of Castle Biosciences's Acquisitions

lockFilter this list
Castle Biosciences has completed a total of 3 acquisitions to date. These 3 acquisitions were all concentrated in 1 country, the United States. Acquisition efforts have engaged 4 distinct sectors, including Oncology (2), Gastroenterology (2), and Genomics (1). The peak acquisition years were 2025 (1 acquisition), 2022 (1 acquisition), and 2021 (1 acquisition). The average number of acquisitions per year over the last five years (2020-2025) is 0.6, with 0 acquisitions completed in the current calendar year. The most recent acquisition was Previse, a Baltimore-based provider of diagnostic tests for cancer detection, founded in 2018 and acquired in May 2025.

Here's the year on year acquisition history of Castle Biosciences:

Year on year acquisition history of Castle Biosciences202520222021Acquisitions Round Date (Yearly)012
  • Number of Total Acquisitions
Year
# Acquisitions
2025
1
2022
1
2021
1

Recent acquisitions by Castle Biosciences

Castle Biosciences's most recent acquisition - Previse is a Provider of diagnostic tests for the detection of cancer, founded in 2018 and located in Baltimore. Castle Biosciences acquired it in May 2025 for a price of $*****.

Here is the list of all acquisitions by Castle Biosciences sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
May 05, 2025
cpbx
czlo
74
664
Apr 04, 2022
mwzv
gwia
98
440
Oct 22, 2021
xqgu
uzgt
59
234

News related to Castle Biosciences's acquisitions

lockFilter this list

Media has covered Castle Biosciences for a total of 37 events in the last 1 year, 4 of them have been about acquisition activity.

View More Castle Biosciences Recent News

FAQs about Acquisitions by Castle Biosciences

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford